KFSH performs nearly two-thirds of liver transplants in Saudi Arabia

RIYADH — King Faisal Specialist Hospital & Research Centre (KFSH) performed approximately 63% of all liver transplants in Saudi Arabia in 2023 and 2024 combined, accounting for nearly two-thirds of the 1,018 procedures recorded by the Saudi Center for Organ Transplantation (SCOT).The hospital also performed nearly half of all kidney transplants conducted across the Kingdom during the same period.KFSH has performed more than 1,000 solid organ transplants annually for four consecutive years, with a total of 4,330 procedures between 2022 and 2025, including 1,109 in 2025 alone.The procedures included kidney, liver, heart, lung, pancreas and intestine transplants.The hospital’s kidney transplant program reported one-year patient and graft survival rates ranging from 97% to 99%.KFSH’s transplant clinics also recorded approximately 86,000 follow-up visits in 2025 as part of an integrated care system aimed at preserving patients’ health and maintaining the long-term function of transplanted organs.The hospital continues to advance surgical techniques in organ transplantation, having performed the world’s first fully robotic liver transplant in 2023, followed by the world’s first fully robotic heart transplant in 2024.These medical milestones have helped reduce surgical trauma associated with complex transplant procedures.KFSH ranked first in the Middle East and Africa and 12th globally among the world’s top 250 academic medical centers for 2026.It was also named the most valuable healthcare brand in Saudi Arabia and the Middle East for 2026 by Brand Finance.The hospital has also been featured in Newsweek’s World’s Best Hospitals 2026, World’s Best Smart Hospitals 2027 and World’s Best Specialized Hospitals 2027 rankings.RIYADH — King Faisal Specialist Hospital & Research Centre (KFSH) performed approximately 63% of all liver transplants in Saudi Arabia in 2023 and 2024 combined, accounting for nearly two-thirds of the 1,018 procedures recorded by the Saudi Center for Organ Transplantation (SCOT).The hospital also performed nearly half of all kidney transplants conducted across the Kingdom during the same period.KFSH has performed more than 1,000 solid organ transplants annually for four consecutive years, with a total of 4,330 procedures between 2022 and 2025, including 1,109 in 2025 alone.The procedures included kidney, liver, heart, lung, pancreas and intestine transplants.The hospital’s kidney transplant program reported one-year patient and graft survival rates ranging from 97% to 99%.KFSH’s transplant clinics also recorded approximately 86,000 follow-up visits in 2025 as part of an integrated care system aimed at preserving patients’ health and maintaining the long-term function of transplanted organs.The hospital continues to advance surgical techniques in organ transplantation, having performed the world’s first fully robotic liver transplant in 2023, followed by the world’s first fully robotic heart transplant in 2024.These medical milestones have helped reduce surgical trauma associated with complex transplant procedures.KFSH ranked first in the Middle East and Africa and 12th globally among the world’s top 250 academic medical centers for 2026.It was also named the most valuable healthcare brand in Saudi Arabia and the Middle East for 2026 by Brand Finance.The hospital has also been featured in Newsweek’s World’s Best Hospitals 2026, World’s Best Smart Hospitals 2027 and World’s Best Specialized Hospitals 2027 rankings.